Alphamab
Alphamab Oncology, established in 2015, is a biopharmaceutical company dedicated to the development, manufacturing and commercialization of cutting-edge innovative biotherapeutics for cancer treatment. On December 12, 2019, Alphamab Oncology was listed on the Main Board of the Hong Kong Stock Exchange, trading under the stock code 9966.[alphamabonc.com]
-
About Follitropin alfa Follitropin alfa is a fertility medication containing recombinant human Follicle-Stimulating Hormone (FSH) used to stimulate egg development in […]
